News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,740 Results
Type
Article (29835)
Company Profile (225)
Press Release (599671)
Multimedia
Podcasts (60)
Webinars (21)
Section
Business (203750)
Career Advice (1150)
Deals (30235)
Drug Delivery (109)
Drug Development (64810)
Employer Resources (159)
FDA (13291)
Job Trends (12448)
News (293045)
Policy (24473)
Tag
2025 Best Places to Work (15)
2026 Best Places to Work (24)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Standard (4)
40 Under 40 (3)
Academia (2255)
Academic (2)
Accelerated approval (53)
ADA (34)
Adcomms (23)
Allergies (150)
Alliances (43214)
ALS (196)
Alzheimer's disease (1594)
Antibody-drug conjugate (ADC) (492)
Approvals (14105)
Artificial intelligence (772)
ASCO (238)
Autoimmune disease (375)
Automation (60)
Bankruptcy (298)
Belgium (21)
Best Places to Work (9762)
BIO (56)
Biologics (97)
BIOSECURE Act (12)
Biosimilars (207)
BioSpace Insights (141)
Biotechnology (122)
Bispecific (50)
Bladder cancer (187)
Brain cancer (62)
Breast cancer (774)
Cancer (5790)
Cardiovascular disease (462)
Career advice (1036)
Career pathing (51)
CAR-T (297)
CDC (39)
CDMO (108)
Celiac Disease (6)
Cell therapy (807)
Cervical cancer (59)
Clinical research (58507)
Collaboration (2146)
Commercialization (49)
Company closure (1)
Compensation (1733)
Complete response letters (56)
COVID-19 (1760)
CRISPR (116)
CRO (6)
C-suite (1393)
Cystic fibrosis (139)
Data (8876)
Decentralized trials (3)
Denatured (35)
Depression (162)
Dermatology (167)
Diabetes (592)
Diagnostics (6322)
Digital health (67)
Diversity (11)
Diversity, equity & inclusion (42)
Drug discovery (379)
Drug pricing (73)
Drug shortages (13)
Duchenne muscular dystrophy (267)
Earnings (81413)
Editorial (28)
Employer branding (25)
Employer resources (142)
ESMO (312)
Events (108390)
Executive appointments (1118)
Eye disease (19)
FDA (17297)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (5)
Friedreich's ataxia (25)
Frontotemporal dementia (31)
Funding (1800)
Gene editing (215)
Generative AI (60)
Gene therapy (594)
GLP-1 (752)
Government (2744)
Grass and pollen (3)
Guidances (375)
Healthcare (15094)
Hematology (163)
HIV (97)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (116)
Immunology and inflammation (194)
Immuno-oncology (105)
Indications (254)
Infectious disease (2056)
Inflammatory bowel disease (213)
Inflation Reduction Act (10)
Influenza (118)
Intellectual property (330)
Interviews (176)
IPO (14151)
IRA (20)
Job creations (2926)
Job search strategy (878)
JPM (30)
Kidney cancer (20)
Kidney disease (132)
Labor market (120)
Layoffs (281)
Leadership (38)
Legal (6275)
Licensing (103)
Liver cancer (74)
Longevity (49)
Lung cancer (806)
Lung diease (15)
Lymphoma (426)
Machine learning (62)
Management (52)
Manufacturing (1027)
Marketing (32)
MASH (170)
Medical affairs (5)
Medical device (11392)
Medtech (11660)
Melanoma (84)
Mergers & acquisitions (17470)
Metabolic disorders (1301)
Middle East (1)
mRNA (167)
Multiple sclerosis (208)
Multispecific (6)
NASH (14)
Netherlands (30)
Neurodegenerative disease (404)
Neuropsychiatric disorders (76)
Neuroscience (3118)
Neurotech (3)
NextGen: Class of 2026 (5231)
Non-profit (3050)
Now hiring (95)
Obesity (516)
Opinion (197)
Ovarian cancer (243)
Pain (268)
Pancreatic cancer (301)
Parkinson's disease (320)
Partnered (35)
Patents (629)
Patient advocacy (7)
Patient recruitment (717)
Patient selection (83)
Peanut (48)
People (55222)
Peptides (34)
Pharmaceutical (44)
Pharmacy benefit managers (14)
Phase 1 (18236)
Phase 2 (25650)
Phase 3 (18909)
Pipeline (11776)
Policy (168)
Postmarket research (2120)
Preclinical (8074)
Press Release (70)
Prostate cancer (298)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (994)
Real estate (4894)
Recruiting (64)
Regenerative medicine (30)
Regulatory (20622)
Reports (76)
Research institute (1970)
Resumes & cover letters (155)
Rett syndrome (53)
RNA editing (17)
RSV (75)
Saudi Arabia (1)
Schizophrenia (166)
Series A (322)
Series B (215)
Series C (1)
Service/supplier (8)
Sickle cell disease (109)
Special edition (17)
Spinal muscular atrophy (137)
Sponsored (29)
Startups (3266)
State (1)
Stem cells (5)
Stomach cancer (10)
Substance use disorders (20)
Supply chain (97)
Switzerland (12)
Tariffs (21)
Tax incentives (1)
The Weekly (25)
Vaccines (721)
Venture capital (130)
Weight loss (270)
Wet AMD (7)
Women's health (148)
Worklife (23)
Date
Today (70)
Last 7 days (555)
Last 30 days (3085)
Last 365 days (25394)
2026 (23364)
2025 (24812)
2024 (29426)
2023 (33827)
2022 (42678)
2021 (46587)
2020 (44284)
2019 (36018)
2018 (26971)
2017 (25733)
2016 (25463)
2015 (31631)
2014 (26926)
2013 (22858)
2012 (24877)
2011 (25483)
2010 (24796)
Location
Africa (550)
Alabama (103)
Alaska (7)
Arizona (416)
Arkansas (14)
Asia (28259)
Australia (4078)
California (15298)
Canada (4039)
China (1093)
Colorado (679)
Connecticut (592)
Delaware (425)
Europe (55733)
Florida (2304)
Georgia (514)
Hawaii (5)
Idaho (54)
Illinois (1113)
India (114)
Indiana (629)
Iowa (34)
Japan (613)
Kansas (135)
Kentucky (48)
Louisiana (56)
Maine (37)
Maryland (1571)
Massachusetts (10629)
Michigan (388)
Minnesota (847)
Mississippi (8)
Missouri (152)
Montana (25)
Nebraska (17)
Nevada (179)
New Hampshire (75)
New Jersey (3785)
New Mexico (26)
New York (3851)
North Carolina (1830)
North Dakota (14)
Northern California (7777)
Ohio (417)
Oklahoma (24)
Oregon (42)
Pennsylvania (2887)
Puerto Rico (28)
Rhode Island (49)
South America (772)
South Carolina (95)
South Dakota (2)
Southern California (6306)
Tennessee (270)
Texas (2567)
United States (52330)
Utah (478)
Vermont (2)
Virginia (253)
Washington D.C. (75)
Washington State (1212)
West Virginia (2)
Wisconsin (164)
Wyoming (2)
629,740 Results for "physical sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
November 17, 2026
·
21 min read
Press Releases
Hemostemix to Highlight Commercial Phase I Longevity Treatment at Small Cap Growth Investor Conference
Quality of LIFE peer reviewed results include 92% improvement in the physical-role score, 58% in physical functioning and 48.6% in vitality.
November 19, 2026
·
9 min read
Press Releases
Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
October 30, 2026
·
18 min read
Press Releases
NYU Langone Health’s Perlmutter Cancer Center Appoints New Vice Chair of Physics and Dosimetry in the Department of Radiation Oncology
September 10, 2026
·
5 min read
Press Releases
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
October 27, 2026
·
13 min read
Press Releases
Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026
November 9, 2026
·
17 min read
Press Releases
Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines
June 17, 2026
·
5 min read
Funding
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
October 16, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Emmaus Life Sciences Reports Quarterly Financial Results - November 18, 2026
November 18, 2026
·
6 min read
Press Releases
Conexeu Sciences Appoints Life Sciences Veteran Daniel M. Bradbury as Chairman of the Board of Directors
November 19, 2026
·
9 min read
1 of 62,974
Next